Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-CHOICE II: P2Y12 Monotherapy vs DAPT after BRS
NCT03119012Phase 4Terminated
- Sponsor
- Samsung Medical Center
- Start
- Apr 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, ticagrelor in coronary artery disease (CAD), sponsored by Samsung Medical Center. Started Apr 2017; status: terminated.
02
Drugs
clopidogrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03119012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119012.